Following the finalization of a joint venture with investment firm CPE, Burger King's parent company RBI has reaffirmed ambitious plans to more than triple its footprint in China over the next decade, backed by a $350 million investment.
Shares of The Chefs' Warehouse (NASDAQ:CHEF) have more than doubled over the past five years, a remarkable run fueled by the company's pivot to profitability. While recent momentum has cooled, analysts point to sustained earnings growth as a key indicator of underlying strength.
In a rare show of unity, Pennsylvania's political leaders from both parties are rallying behind the state's famed weather-predicting groundhog, pushing back against an animal rights group's call to replace the living animal with a digital projection.
Despite lagging the S&P 500 over the past year, DoorDash retains overwhelming 'Strong Buy' ratings from analysts who see significant upside potential, even after a volatile post-earnings sell-off.
Amazon is discontinuing its Amazon One biometric palm payment system in 2026, ending a nearly six-year experiment in contactless retail technology that faced scrutiny over data security.
As the wearables market surges, Biolinq CEO Richard Yang positions smart patches as the next evolution, capable of tracking deep biochemical data where watches track surface metrics, with his company's FDA-cleared glucose sensor leading the charge.
BofA Securities has trimmed its price target for Uber Technologies, citing near-term uncertainties in the autonomous vehicle sector, even as the company launches a new internal data initiative aimed at accelerating AV development.
While value investing promises bargains, some discounted stocks carry hidden risks. We examine three companies trading at low multiples but facing significant headwinds that warrant investor caution.
While trading near 52-week highs can signal strength, it can also precede a correction. We examine three stocks where current valuations may not justify the price tag, urging investors to look beyond the hype.
Cogent Biosciences secures a key FDA Breakthrough Therapy Designation for its bezuclastinib-sunitinib combination in advanced GIST, following promising Phase 3 data that showed a halving of disease progression risk.
As Japan heads to the polls, Prime Minister Sanae Takaichi's expansionary fiscal pledges are being put to the test in a critical 30-year bond auction, with investors wary of the nation's towering debt burden.
Glaukos Corporation's iDose TR glaucoma therapy receives a key FDA labeling update, permitting repeat administration. While the news bolsters the company's growth narrative, analysts are divided on whether its current stock price already reflects future potential amid rich valuation metrics.
Shares of Colgate-Palmolive jumped over 6% as the consumer goods giant outlined a resilient growth plan through 2026, even after reporting a significant profit decline in a tough operating climate.
Baidu's flagship AI assistant, Ernie, has surpassed 200 million monthly active users, a milestone reported by the Wall Street Journal. The growth underscores Baidu's deepening integration of AI across its ecosystem amid fierce competition with domestic tech rivals.
While low-volatility stocks offer a haven in turbulent markets, their perceived safety can sometimes obscure underlying financial weaknesses. We examine three such stocks where calm trading patterns may not justify their current valuations or growth prospects.
Campbell Soup Company will shutter its Hyannis, Massachusetts facility, the original home of Cape Cod Potato Chips, citing economic inefficiency. The closure, affecting 49 jobs, marks a strategic shift of production to larger plants as the snack giant consolidates its network.
Analyst sell ratings are rare on Wall Street, making them noteworthy when they appear. We examine one such case where pessimism may have gone too far, creating a potential opportunity, alongside two stocks where the cautious outlook appears justified.
Profitability is a crucial starting point for investors, but it's not a guaranteed shield against market shifts. As competition evolves, today's cash generators can become tomorrow's laggards. We analyze three companies with strong margins to separate resilient growth from potential stagnation.
While the allure of finding the next undervalued gem is strong, some stocks trading at low multiples may be cheap for a reason. We examine three companies where fundamental challenges could outweigh their seemingly attractive valuations.
U.S. producer prices rose more than expected in December, driven by the largest increase in service costs in months, complicating the inflation outlook as the Federal Reserve weighs its next policy move.
